Variant report
Variant | esv3482975 |
---|---|
Chromosome Location | chr9:12580707-12616472 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs547251670 | chr9:12595605-12595606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs116213293 | chr9:12595616-12595617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538643610 | chr9:12595617-12595618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376454833 | chr9:12595660-12595661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150466112 | chr9:12595711-12595712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533878049 | chr9:12595712-12595713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574996317 | chr9:12595738-12595739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539143553 | chr9:12595749-12595750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182677582 | chr9:12595790-12595791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554382328 | chr9:12595803-12595804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs187805352 | chr9:12595811-12595812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540183589 | chr9:12595841-12595842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201057630 | chr9:12595865-12595866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201879293 | chr9:12595866-12595867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs77961228 | chr9:12595879-12595880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs71507323 | chr9:12595889-12595890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79376660 | chr9:12595906-12595907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545425252 | chr9:12595915-12595916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs118073831 | chr9:12595947-12595948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531069070 | chr9:12595950-12595951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189436470 | chr9:12598824-12598825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144010408 | chr9:12598842-12598843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574785517 | chr9:12598856-12598857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34803310 | chr9:12598870-12598871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs570500664 | chr9:12598877-12598878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539575537 | chr9:12598888-12598889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540306459 | chr9:12598907-12598908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553882215 | chr9:12598917-12598918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556262902 | chr9:12598955-12598956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570101736 | chr9:12598963-12598964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535683106 | chr9:12598967-12598968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs371933164 | chr9:12599022-12599023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555882688 | chr9:12599041-12599042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182068930 | chr9:12599074-12599075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576940032 | chr9:12599080-12599081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545566012 | chr9:12599084-12599085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146449959 | chr9:12599121-12599122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557820446 | chr9:12599151-12599152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529740114 | chr9:12599156-12599157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577688972 | chr9:12599183-12599184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573847643 | chr9:12599228-12599229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376371802 | chr9:12599230-12599231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs114661447 | chr9:12599266-12599267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542458043 | chr9:12599286-12599287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559493844 | chr9:12599292-12599293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs528412714 | chr9:12599300-12599301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551242479 | chr9:12599338-12599339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542134310 | chr9:12599383-12599384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562545580 | chr9:12599386-12599387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs367958791 | chr9:12599388-12599389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21611746 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
Chordoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:12595600-12596000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr9:12598800-12599800 | Enhancers | Fetal Heart | heart |
3 | chr9:12599800-12604000 | Weak transcription | Fetal Heart | heart |
4 | chr9:12604000-12604400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr9:12604000-12604600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
6 | chr9:12604000-12604600 | Enhancers | HMEC | breast |
7 | chr9:12604000-12605200 | Enhancers | Fetal Heart | heart |
8 | chr9:12604000-12605200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
9 | chr9:12604200-12604600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr9:12604200-12604600 | Enhancers | Psoas Muscle | Psoas |
11 | chr9:12604600-12605800 | Weak transcription | Psoas Muscle | Psoas |
12 | chr9:12606000-12606200 | Enhancers | Psoas Muscle | Psoas |
13 | chr9:12612200-12613000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr9:12612600-12613800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr9:12615600-12615800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr9:12615600-12615800 | Enhancers | Fetal Lung | lung |
17 | chr9:12615800-12616600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |